世界のCD38モノクローナル抗体市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP02282)
◆英語タイトル:Global CD38 Monoclonal Antibodies Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP02282
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月18日(※2024年版があります。お問い合わせください。)
◆ページ数:104
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、CD38モノクローナル抗体の世界市場を広く調査・分析し、今後の市場展望をまとめております。CD38モノクローナル抗体の種類別市場規模(ダラツマブ、イサツキシマブ)、用途別市場規模(薬局、研究室)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Johnson & Johnson、Carbosynth、Sanofi、Janssen Biotech、BOC Sciences、Creative Biolabs
・地域別グローバル市場分析 2015年-2020年
・CD38モノクローナル抗体の北米市場(アメリカ、カナダ、メキシコ)
・CD38モノクローナル抗体のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・CD38モノクローナル抗体のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・CD38モノクローナル抗体の南米市場(ブラジル、アルゼンチン)
・CD38モノクローナル抗体の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ダラツマブ、イサツキシマブ
・用途別分析:薬局、研究室
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The CD38 Monoclonal Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global CD38 Monoclonal Antibodies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
CD38 Monoclonal Antibodies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, CD38 Monoclonal Antibodies market has been segmented into:
Daratumumab
Isatuximab

By Application, CD38 Monoclonal Antibodies has been segmented into:
Pharmacy
Laboratory Use

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global CD38 Monoclonal Antibodies market presented in the report. This section sheds light on the sales growth of different regional and country-level CD38 Monoclonal Antibodies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global CD38 Monoclonal Antibodies market.

The report offers in-depth assessment of the growth and other aspects of the CD38 Monoclonal Antibodies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and CD38 Monoclonal Antibodies Market Share Analysis
CD38 Monoclonal Antibodies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, CD38 Monoclonal Antibodies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the CD38 Monoclonal Antibodies sales, revenue and market share for each player covered in this report.

The major players covered in CD38 Monoclonal Antibodies are:
Johnson & Johnson
Carbosynth
Sanofi
Janssen Biotech
BOC Sciences
Creative Biolabs
Among other players domestic and global, CD38 Monoclonal Antibodies market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 CD38 Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of CD38 Monoclonal Antibodies
1.2 Classification of CD38 Monoclonal Antibodies by Type
1.2.1 Global CD38 Monoclonal Antibodies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global CD38 Monoclonal Antibodies Revenue Market Share by Type in 2019
1.2.3 Daratumumab
1.2.4 Isatuximab
1.3 Global CD38 Monoclonal Antibodies Market by Application
1.3.1 Overview: Global CD38 Monoclonal Antibodies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmacy
1.3.3 Laboratory Use
1.4 Global CD38 Monoclonal Antibodies Market by Regions
1.4.1 Global CD38 Monoclonal Antibodies Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of CD38 Monoclonal Antibodies (2015-2025)
1.4.3 North America (USA, Canada and Mexico) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson SWOT Analysis
2.1.4 Johnson & Johnson Product and Services
2.1.5 Johnson & Johnson CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.2 Carbosynth
2.2.1 Carbosynth Details
2.2.2 Carbosynth Major Business
2.2.3 Carbosynth SWOT Analysis
2.2.4 Carbosynth Product and Services
2.2.5 Carbosynth CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.4 Janssen Biotech
2.4.1 Janssen Biotech Details
2.4.2 Janssen Biotech Major Business
2.4.3 Janssen Biotech SWOT Analysis
2.4.4 Janssen Biotech Product and Services
2.4.5 Janssen Biotech CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.5 BOC Sciences
2.5.1 BOC Sciences Details
2.5.2 BOC Sciences Major Business
2.5.3 BOC Sciences SWOT Analysis
2.5.4 BOC Sciences Product and Services
2.5.5 BOC Sciences CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.6 Creative Biolabs
2.6.1 Creative Biolabs Details
2.6.2 Creative Biolabs Major Business
2.6.3 Creative Biolabs Product and Services
2.6.4 Creative Biolabs CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global CD38 Monoclonal Antibodies Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 CD38 Monoclonal Antibodies Players Market Share
3.2.2 Top 10 CD38 Monoclonal Antibodies Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global CD38 Monoclonal Antibodies Revenue and Market Share by Regions
4.2 North America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.3 Europe CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.5 South America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
5 North America CD38 Monoclonal Antibodies Revenue by Countries
5.1 North America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
5.2 USA CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
5.3 Canada CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
5.4 Mexico CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6 Europe CD38 Monoclonal Antibodies Revenue by Countries
6.1 Europe CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
6.2 Germany CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.3 UK CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.4 France CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.5 Russia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.6 Italy CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7 Asia-Pacific CD38 Monoclonal Antibodies Revenue by Countries
7.1 Asia-Pacific CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
7.2 China CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.3 Japan CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.4 Korea CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.5 India CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
8 South America CD38 Monoclonal Antibodies Revenue by Countries
8.1 South America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
8.2 Brazil CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
8.3 Argentina CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue CD38 Monoclonal Antibodies by Countries
9.1 Middle East & Africa CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
9.2 Saudi Arabia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9.3 UAE CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9.4 Egypt CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9.5 South Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global CD38 Monoclonal Antibodies Revenue and Market Share by Type (2015-2020)
10.2 Global CD38 Monoclonal Antibodies Market Forecast by Type (2019-2024)
10.3 Daratumumab Revenue Growth Rate (2015-2025)
10.4 Isatuximab Revenue Growth Rate (2015-2025)
11 Global CD38 Monoclonal Antibodies Market Segment by Application
11.1 Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
11.2 CD38 Monoclonal Antibodies Market Forecast by Application (2019-2024)
11.3 Pharmacy Revenue Growth (2015-2020)
11.4 Laboratory Use Revenue Growth (2015-2020)
12 Global CD38 Monoclonal Antibodies Market Size Forecast (2021-2025)
12.1 Global CD38 Monoclonal Antibodies Market Size Forecast (2021-2025)
12.2 Global CD38 Monoclonal Antibodies Market Forecast by Regions (2021-2025)
12.3 North America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.4 Europe CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.6 South America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Johnson & Johnson、Carbosynth、Sanofi、Janssen Biotech、BOC Sciences、Creative Biolabs

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のCD38モノクローナル抗体市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global CD38 Monoclonal Antibodies Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。